Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison J Moskowitz

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Blood|August 25, 2010
Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphomaAlison J Moskowitz, Joachim Yahalom, Tarun Kewalramani, et al.
Oncology (Williston Park, N.Y.)|May 16, 2022
Current Treatment of Peripheral T-cell LymphomaRobert Stuver, Zachary D Epstein-Peterson, William T Johnson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2017
Accelerated Total Lymphoid Irradiation-containing Salvage Regimen for Patients With Refractory and Relapsed Hodgkin Lymphoma: 20 Years of ExperienceAndreas Rimner, Shona Lovie, Meier Hsu, et al.
British Journal of Haematology|May 15, 2009
Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphomaAlison J Moskowitz, Miguel-Angel Perales, Tarun Kewalramani, et al.
Journal of the American Academy of Dermatology|December 3, 2014
Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: a single-center, retrospective studyMichael A Marchetti, Melissa P Pulitzer, Patricia L Myskowski, et al.
Genes, Chromosomes & Cancer|August 12, 2024
A Novel JAK2 Fusion in T-Cell Prolymphocytic LeukemiaOzgur Can Eren, Robert Stuver, Ting Zhou, et al.
Cytometry. Part B, Clinical Cytometry|April 22, 2022
PD-1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndromeNatasha E Lewis, Qi Gao, Kseniya Petrova-Drus, et al.
Blood Advances|April 20, 2018
Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphomaAnita Kumar, Santosha Vardhana, Alison J Moskowitz, et al.
Leukemia & Lymphoma|July 26, 2021
Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trialSteven Horwitz, Pier Luigi Zinzani, Martine Bagot, et al.
Cancers|January 28, 2026
Phase I Study of Mogamulizumab in Combination with Pembrolizumab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma-A National Cancer Institute Experimental Therapeutics Clinical Trials Network (NCI-ETCTN) TrialErel Joffe, Anita Kumar, Joseph M Tuscano, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Blood|August 25, 2010
Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphomaAlison J Moskowitz, Joachim Yahalom, Tarun Kewalramani, et al.
Oncology (Williston Park, N.Y.)|May 16, 2022
Current Treatment of Peripheral T-cell LymphomaRobert Stuver, Zachary D Epstein-Peterson, William T Johnson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2017
Accelerated Total Lymphoid Irradiation-containing Salvage Regimen for Patients With Refractory and Relapsed Hodgkin Lymphoma: 20 Years of ExperienceAndreas Rimner, Shona Lovie, Meier Hsu, et al.
British Journal of Haematology|May 15, 2009
Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphomaAlison J Moskowitz, Miguel-Angel Perales, Tarun Kewalramani, et al.
Journal of the American Academy of Dermatology|December 3, 2014
Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: a single-center, retrospective studyMichael A Marchetti, Melissa P Pulitzer, Patricia L Myskowski, et al.
Genes, Chromosomes & Cancer|August 12, 2024
A Novel JAK2 Fusion in T-Cell Prolymphocytic LeukemiaOzgur Can Eren, Robert Stuver, Ting Zhou, et al.
Cytometry. Part B, Clinical Cytometry|April 22, 2022
PD-1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndromeNatasha E Lewis, Qi Gao, Kseniya Petrova-Drus, et al.
Blood Advances|April 20, 2018
Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphomaAnita Kumar, Santosha Vardhana, Alison J Moskowitz, et al.
Leukemia & Lymphoma|July 26, 2021
Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trialSteven Horwitz, Pier Luigi Zinzani, Martine Bagot, et al.
Cancers|January 28, 2026
Phase I Study of Mogamulizumab in Combination with Pembrolizumab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma-A National Cancer Institute Experimental Therapeutics Clinical Trials Network (NCI-ETCTN) TrialErel Joffe, Anita Kumar, Joseph M Tuscano, et al.
Pageof 10